Imatinib Mesylate
- Product NDC
- 50268-426
- 11-digit product format
- 502680426
- Labeler code
- 50268
- Product ID
- 50268-426_d5ddafe4-4a9b-1881-e053-2a95a90ae245
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Imatinib Mesylate
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- AvPAK
- Application
- ANDA079179
- Marketing category
- ANDA
- Marketing start
- 2017-08-24
- Marketing end
- 0000-00-00
- Substance
- IMATINIB MESYLATE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50268-426-12 | 50268042612 | 20 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-426-12) > 1 TABLET, FILM COATED in 1 BLISTER PACK (50268-426-11) | 20 blister pack | 2017-08-24 | 0000-00-00 | No | No | Current |